Cargando…

The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion

High-mobility group box 1 (HMGB1) is a nuclear factor that is released extracellularly as a late mediator of lethality in sepsis as well as after necrotic, but not apoptotic, death. Here we demonstrate that in contrast to the delayed role of HMGB1 in the systemic inflammation of sepsis, HMGB1 acts a...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsung, Allan, Sahai, Rohit, Tanaka, Hiroyuki, Nakao, Atsunori, Fink, Mitchell P., Lotze, Michael T., Yang, Huan, Li, Jianhua, Tracey, Kevin J., Geller, David A., Billiar, Timothy R.
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2213120/
https://www.ncbi.nlm.nih.gov/pubmed/15795240
http://dx.doi.org/10.1084/jem.20042614
_version_ 1782148829217292288
author Tsung, Allan
Sahai, Rohit
Tanaka, Hiroyuki
Nakao, Atsunori
Fink, Mitchell P.
Lotze, Michael T.
Yang, Huan
Li, Jianhua
Tracey, Kevin J.
Geller, David A.
Billiar, Timothy R.
author_facet Tsung, Allan
Sahai, Rohit
Tanaka, Hiroyuki
Nakao, Atsunori
Fink, Mitchell P.
Lotze, Michael T.
Yang, Huan
Li, Jianhua
Tracey, Kevin J.
Geller, David A.
Billiar, Timothy R.
author_sort Tsung, Allan
collection PubMed
description High-mobility group box 1 (HMGB1) is a nuclear factor that is released extracellularly as a late mediator of lethality in sepsis as well as after necrotic, but not apoptotic, death. Here we demonstrate that in contrast to the delayed role of HMGB1 in the systemic inflammation of sepsis, HMGB1 acts as an early mediator of inflammation and organ damage in hepatic ischemia reperfusion (I/R) injury. HMGB1 levels were increased during liver I/R as early as 1 h after reperfusion and then increased in a time-dependent manner up to 24 h. Inhibition of HMGB1 activity with neutralizing antibody significantly decreased liver damage after I/R, whereas administration of recombinant HMGB1 worsened I/R injury. Treatment with neutralizing antibody was associated with less phosphorylation of c-Jun NH(2)-terminal kinase and higher nuclear factor–κB DNA binding in the liver after I/R. Toll-like receptor 4 (TLR4)-defective (C3H/Hej) mice exhibited less damage in the hepatic I/R model than did wild-type (C3H/HeOuj) mice. Anti-HMGB1 antibody failed to provide protection in C3H/Hej mice, but successfully reduced damage in C3H/Ouj mice. Together, these results demonstrate that HMGB1 is an early mediator of injury and inflammation in liver I/R and implicates TLR4 as one of the receptors that is involved in the process.
format Text
id pubmed-2213120
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-22131202008-03-11 The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion Tsung, Allan Sahai, Rohit Tanaka, Hiroyuki Nakao, Atsunori Fink, Mitchell P. Lotze, Michael T. Yang, Huan Li, Jianhua Tracey, Kevin J. Geller, David A. Billiar, Timothy R. J Exp Med Article High-mobility group box 1 (HMGB1) is a nuclear factor that is released extracellularly as a late mediator of lethality in sepsis as well as after necrotic, but not apoptotic, death. Here we demonstrate that in contrast to the delayed role of HMGB1 in the systemic inflammation of sepsis, HMGB1 acts as an early mediator of inflammation and organ damage in hepatic ischemia reperfusion (I/R) injury. HMGB1 levels were increased during liver I/R as early as 1 h after reperfusion and then increased in a time-dependent manner up to 24 h. Inhibition of HMGB1 activity with neutralizing antibody significantly decreased liver damage after I/R, whereas administration of recombinant HMGB1 worsened I/R injury. Treatment with neutralizing antibody was associated with less phosphorylation of c-Jun NH(2)-terminal kinase and higher nuclear factor–κB DNA binding in the liver after I/R. Toll-like receptor 4 (TLR4)-defective (C3H/Hej) mice exhibited less damage in the hepatic I/R model than did wild-type (C3H/HeOuj) mice. Anti-HMGB1 antibody failed to provide protection in C3H/Hej mice, but successfully reduced damage in C3H/Ouj mice. Together, these results demonstrate that HMGB1 is an early mediator of injury and inflammation in liver I/R and implicates TLR4 as one of the receptors that is involved in the process. The Rockefeller University Press 2005-04-04 /pmc/articles/PMC2213120/ /pubmed/15795240 http://dx.doi.org/10.1084/jem.20042614 Text en Copyright © 2005, The Rockefeller University Press This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Article
Tsung, Allan
Sahai, Rohit
Tanaka, Hiroyuki
Nakao, Atsunori
Fink, Mitchell P.
Lotze, Michael T.
Yang, Huan
Li, Jianhua
Tracey, Kevin J.
Geller, David A.
Billiar, Timothy R.
The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion
title The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion
title_full The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion
title_fullStr The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion
title_full_unstemmed The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion
title_short The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion
title_sort nuclear factor hmgb1 mediates hepatic injury after murine liver ischemia-reperfusion
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2213120/
https://www.ncbi.nlm.nih.gov/pubmed/15795240
http://dx.doi.org/10.1084/jem.20042614
work_keys_str_mv AT tsungallan thenuclearfactorhmgb1mediateshepaticinjuryaftermurineliverischemiareperfusion
AT sahairohit thenuclearfactorhmgb1mediateshepaticinjuryaftermurineliverischemiareperfusion
AT tanakahiroyuki thenuclearfactorhmgb1mediateshepaticinjuryaftermurineliverischemiareperfusion
AT nakaoatsunori thenuclearfactorhmgb1mediateshepaticinjuryaftermurineliverischemiareperfusion
AT finkmitchellp thenuclearfactorhmgb1mediateshepaticinjuryaftermurineliverischemiareperfusion
AT lotzemichaelt thenuclearfactorhmgb1mediateshepaticinjuryaftermurineliverischemiareperfusion
AT yanghuan thenuclearfactorhmgb1mediateshepaticinjuryaftermurineliverischemiareperfusion
AT lijianhua thenuclearfactorhmgb1mediateshepaticinjuryaftermurineliverischemiareperfusion
AT traceykevinj thenuclearfactorhmgb1mediateshepaticinjuryaftermurineliverischemiareperfusion
AT gellerdavida thenuclearfactorhmgb1mediateshepaticinjuryaftermurineliverischemiareperfusion
AT billiartimothyr thenuclearfactorhmgb1mediateshepaticinjuryaftermurineliverischemiareperfusion
AT tsungallan nuclearfactorhmgb1mediateshepaticinjuryaftermurineliverischemiareperfusion
AT sahairohit nuclearfactorhmgb1mediateshepaticinjuryaftermurineliverischemiareperfusion
AT tanakahiroyuki nuclearfactorhmgb1mediateshepaticinjuryaftermurineliverischemiareperfusion
AT nakaoatsunori nuclearfactorhmgb1mediateshepaticinjuryaftermurineliverischemiareperfusion
AT finkmitchellp nuclearfactorhmgb1mediateshepaticinjuryaftermurineliverischemiareperfusion
AT lotzemichaelt nuclearfactorhmgb1mediateshepaticinjuryaftermurineliverischemiareperfusion
AT yanghuan nuclearfactorhmgb1mediateshepaticinjuryaftermurineliverischemiareperfusion
AT lijianhua nuclearfactorhmgb1mediateshepaticinjuryaftermurineliverischemiareperfusion
AT traceykevinj nuclearfactorhmgb1mediateshepaticinjuryaftermurineliverischemiareperfusion
AT gellerdavida nuclearfactorhmgb1mediateshepaticinjuryaftermurineliverischemiareperfusion
AT billiartimothyr nuclearfactorhmgb1mediateshepaticinjuryaftermurineliverischemiareperfusion